The deactivation of implantab le cardioverter-defib rillators: Medical, ethical, practical, and legal considerations;Deaktivierung von implantierbaren Defibrillatoren: Medizinische, ethische, praktische und juristische Aspekte

Deutsches Arzteblatt International

Volumn 109, Issue 33-34, 2012, Pages 535-541

  Carlsson, Jörg ^a   Paul, Norbert W ^b   Dann, Matthias ^c   Neuzner, Jörg ^d   Pfeiffer, Dietrich ^e  

^a KALMAR COUNTY HOSPITAL   (Sweden)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Department of Cardiology and Intensive Care Klinikum Kassel ^*

^d KLINIKUM KASSEL   (Germany)

^e UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CONSENSUS; DECISION MAKING; DISEASE COURSE; ELECTROSTIMULATION THERAPY; HEART FAILURE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEGAL ASPECT; MEDICAL ETHICS; MEDLINE; PALLIATIVE THERAPY; PATIENT CARE; QUALITY OF LIFE; REVIEW; TERMINALLY ILL PATIENT;

EID: 84899774743     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2012.0535     Document Type: Review

References (43)

1. Myerburg RJ, Reddy V, Castellanos A: Indications for implantable cardioverter-defibrillators based on evidence and judgement. J Am Coll Cardiol 2009; 54: 747-63.
2. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al.: ACC/AHA/HRS 2008 guidelines for devicebased therapy of cardiac rhythm abnormalities. J Am Coll Cardiol 2008; 51: e1-e62.
3. Camm AJ, Nisam S: European utilization of the implantable defibrillator: has 10 years changed the "enigma"? Europace 2010; 12: 1063-9.
4. Gadler F: Svenska ICD- och Pacemakerregistret. www.pacemakerregistret.se
5. Fromme EK, Lugliani Stewart T, Jeppesen M, Tolle SW: Adverse experiences with implantable defibrillators in Oregon Hospices. Am Hosp Hosp Palliat Care 2011; 28: 304-9.
6. Padeletti L, Arnar DO, Boncinelli L, et al.: European Heart Rhythm Association expert consensus statement on the management of cardiovascular electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 2010; 12: 1480-9.
7. Lampert R, Hayes DL, Annas GJ, et al.: Heart Rhythm Society expert consensus statement on the management of cardiovascular electronic devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm 2010; 7: 1008-26.
8. Thibodeau JB, Pillarisetti J, Khumri TM, Jones PG, Main ML: Mortality rates and clinical predictors of reduced survival after cardioverter defibrillator implantation. Am J Cardiol 2008; 101: 861-4.
9. Vidal B, Delgado V, Mont L, et al.: Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure. Eur J Heart Fail 2010; 12: 283-7.
10. Paul, NW: Diagnose und Prognose. In: Schulz S, Steigleder K, Fangerau H, Paul NW (eds.): Geschichte, Theorie und Ethik der Medizin: Eine Einführung. Frankfurt/M: Suhrkamp 2006; 143-52.
11. England R, England T, Coggon J: The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer. J Med Ethics 2007; 33: 538-40.
12. Sulmasy DP: Within you/without you: biotechnology, ontology, and ethics. J Gen Intern Med 2007; 23 (suppl 1): 69-72.
13. Zellner RA, Aulisio MP, Lewis WR: Should implantable cardioverter- defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminal illness. Patient autonomy is paramount. Circ Arrhythmia Electrophysiol 2009; 2: 340-4.
14. Kay GN, Bittner GT: Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction. Circ Arrhythmia Electrophysiol 2009; 2: 336-9.
15. Wu EB: The ethics of implantable devices. J Med Ethics 2007; 33: 532-3.
16. Facciorusso A, Stanislao M, Fanelli M, Valori VM, Valle G: Ethical issues on defibrillator deactivation in end-of-life patients. J Cardiovasc Med 2011; 12: 498-500.
17. Goldstein NE, Mehta D, Siddiqui S, et al.: "That's like an act of suicide": patients attitudes towards deactivation of implantable defibrillators. J Gen Intern Med 2008; 23 (suppl 1): 7-12.
18. Goldstein NE, Mehta D, Teitelbaum E, Bradley EH, Morrison RS: "It's like crossing a bridge" Complexities preventing physicians from discussing deactivation of implantable defibrillator at the end of life. J Gen Intern Med 2007; 23 (suppl 1): 2-6.
19. Goldstein NE, Bradley E, Zeidman J, Mehta D, Morrison RS: Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients. J Am Coll Cardiol 2009; 54: 371-3.
20. Stewart GC, Weintraub JR, Semigran MJ, et al.: Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail 2010; 16: 106-13.
21. Kelley AS, Reid MC, Miller DH, Fins JJ, Lachs MS: Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey. Am Heart J 2009; 157: 702-8.
22. Sherazi S, Daubert JP, Block RC, et al.: Physician's preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc 2008; 83: 1139-41.
23. Paul NW: Klinische Ethikberatung: Therapieziele, Patientenwille und Entscheidungsprobleme in der modernen Medizin. In: Junginger T, Perneczky A, VAHL CF, Werner C (eds.): Grenzsituationen der Intensivmedizin: Entscheidungsgrundlagen. Heidelberg:Springer 2008; 207-17.
24. Paul NW: Clinical Ethics Counseling: Therapeutic Goals, the Patient's Will and Decision-making Problems in Modern Medicine. Formosan Journal of Medical Humanities 2010; 11: 19-36.
25. Beets MT, Forringer E: Urgent implantable cardioverter defibrillator deactivation by unconventional means. J Pain Symptom Manage 2011; 42: 941-5.
26. Trappe HJ, Gummert J: Current pacemaker and defibrillator therapy. Dtsch Arztebl Int 2011 108(21): 372-80
27. Nambisan V, Chao D: Dying and defibrillation: a shocking experience. Palliat Med 2004 18: 482-3
28. Rizzieri AG, Verheijde JL, Rady MY, McGregor JL: Ethical challenges with the left ventricular assist device as a destination therapy. Philos Ethics Humanit Med 2008; 3: 20.
29. Lindblad A, Juth N, Fürst CJ, Lynöe N: When enough is enough; terminating life-sustaining treatment at the patient's request: a survey of attitudes among Swedish physicians and the general public. J Med Ethics 2010; 36: 284-9.
30. Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH: Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol 2011; 107: 1071-5.
31. Morrison LJ, Calvin AO, Nora H, Porter Storey C Jr.: Managing cardiac devices near the end of life: a survey of hospice and palliative care providers. Am J Hosp Palliat Care 2010; 27: 545-51.
32. Kramer DB, Kesselheim AS, Brock DW, Maisel WH: Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment. Heart Rhythm 2010; 7: 1537-42.
33. Marinskis G, van Erven L, HER Scientific Initiatives Committee: Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey. Europace 2010; 12: 1176-7.
34. Rady MY, Verheijde JL: End-of-life discontinuation of destination therapy with cardiac and ventilatory support medical devices: physician-assisted death or allowing the patient to die? BMC Medical Ethics 2010 11: 15.
35. Dev S, Galanos AN: Complexities of defibrillator deactivation. Ann Intern Med 2010 153: 133-4.
36. Mueller PS, Swetz KM, Freeman MR, Carter KA, Crowley ME, Severson CJ, Park SJ, Sulmasy DP: Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc 2010; 85: 791-7.
37. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM: Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004; 141: 835-8.
38. Berger JT: The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med 2005; 142: 631-4.
39. Oorschot B, Simon A: Aktive, passive oder indirekte Sterbehilfe? Über subjektive Definitionen und Klassifikationen von Ärzten und Richtern in Entscheidungssituationen am Lebensende. Psychologie & Gesellschaftskritik 2008; 32: 39-53.
40. Kapa S, Mueller PS, Hayes DL, Asirvatham SJ: Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at the end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc 2010; 85: 981-90.
41. Mueller PS, Hook C, Hayes DL: Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support and the end of life. Mayo Clin Proc 2003; 78: 959-63.
42. Raphael C, Kanagaratnam P, Francis DP: Further barriers to conversations about deactivation of implantable cardioverterdefibrillators. J Am Coll Cardiol 2010; 55: 701-2.
43. http://juris.bundesgerichtshof.de/cgi-bin/rechtsprechung/document.py? Gericht=bgh&Art=en&Datum=2010-6&Seite=1&nr=52999&pos= 49&anz=313